Review
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 28, 2020; 26(24): 3344-3364
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3344
Intestinal Ca2+ absorption revisited: A molecular and clinical approach
Vanessa A Areco, Romina Kohan, Germán Talamoni, Nori G Tolosa de Talamoni, María E Peralta López
Vanessa A Areco, Romina Kohan, Germán Talamoni, Nori G Tolosa de Talamoni, María E Peralta López, Laboratorio “Dr. Fernando Cañas”, Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Córdoba 5000, Argentina
Author contributions: Areco VA, Kohan R, Talamoni G, Tolosa de Talamoni NG and Peralta López ME participated in the collection of information, analysis, organization of the information, writing, preparation of figure and table and final editing.
Supported by Consejo Nacional de Investigaciones Cientí ficas y Tecnoló gicas, Argentina PIP 2017-2019, No. 11220170100012CO; and Secretarí a de Ciencia y Té cnica de la Universidad Nacional de Có rdoba, Argentina (Programa 2018-2019), No. 30920180100056CB.
Conflict-of-interest statement: The authors declare that there are no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Nori G Tolosa de Talamoni, PhD, Professor, Laboratorio “Dr. Fernando Cañas”, Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, Córdoba 5000, Argentina. ntolosa@biomed.fcm.unc.edu.ar
Received: February 26, 2020
Peer-review started: February 26, 2020
First decision: May 1, 2020
Revised: May 11, 2020
Accepted: June 10, 2020
Article in press: June 10, 2020
Published online: June 28, 2020
Processing time: 122 Days and 19.5 Hours
Abstract

Ca2+ has an important role in the maintenance of the skeleton and is involved in the main physiological processes. Its homeostasis is controlled by the intestine, kidney, bone and parathyroid glands. The intestinal Ca2+ absorption occurs mainly via the paracellular and the transcellular pathways. The proteins involved in both ways are regulated by calcitriol and other hormones as well as dietary factors. Fibroblast growth factor 23 (FGF-23) is a strong antagonist of vitamin D action. Part of the intestinal Ca2+ movement seems to be vitamin D independent. Intestinal Ca2+ absorption changes according to different physiological conditions. It is promoted under high Ca2+ demands such as growth, pregnancy, lactation, dietary Ca2+ deficiency and high physical activity. In contrast, the intestinal Ca2+ transport decreases with aging. Oxidative stress inhibits the intestinal Ca2+ absorption whereas the antioxidants counteract the effects of prooxidants leading to the normalization of this physiological process. Several pathologies such as celiac disease, inflammatory bowel diseases, Turner syndrome and others occur with inhibition of intestinal Ca2+ absorption, some hypercalciurias show Ca2+ hyperabsorption, most of these alterations are related to the vitamin D endocrine system. Further research work should be accomplished in order not only to know more molecular details but also to detect possible therapeutic targets to ameliorate or avoid the consequences of altered intestinal Ca2+ absorption.

Keywords: Ca2+ absorption; Transcellular pathway; Paracellular pathway; Hormones; Dietary calcium; Physiological conditions; Pathological alterations

Core tip: The intestinal Ca2+ absorption occurs mainly via the paracellular and the transcellular pathways. Both ways are regulated by calcitriol and other hormones as well as dietary factors. Fibroblast growth factor 23 (FGF-23) is a strong antagonist of vitamin D action. Part of the intestinal Ca2+ movement seems to be vitamin D independent. Intestinal Ca2+ absorption changes according to different physiological conditions. Oxidative stress inhibits the intestinal Ca2+ absorption whereas the antioxidants counteract the prooxidant effects. Most diseases that occur with altered intestinal Ca2+ absorption is related to changes in the vitamin D endocrine system. Further research could clarify many unknown points in this subject.